IDSA journals manuscript review CME program
The Infectious Diseases Society of America offers category 1 CME credit for reviewing manuscripts. Only reviews received on time and judged satisfactory by the Editor(s) responsible for the particular manuscript will be eligible for CME credit. We only provide CME credit to reviewers if they request CME credit at the time they complete their review.
The features that contribute most importantly to the quality of manuscript reviews for the Journal include: adherence to reviewer guidelines, specificity and accuracy, completeness, usefulness of recommendations to both editors and authors, tone, internal consistency, and mindfulness of the needs of our readers and the medical community as a whole.
To prepare a high quality review, the reviewer should consider existing evidence when preparing his or her comments. The reviewer should place the current work in the context of existing evidence in the area, describe the unique contributions of the current work, and comment on any inconsistencies of the current work with previous research in your area.
You will be notified via email if your review of the assigned manuscript was completed on time and if it met our criteria for CME credit.
Statement
The Infectious Diseases Society of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. IDSA designates each manuscript review for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians are eligible for up to 3 CME credits for each manuscript review, up to a total of 15 per year.
Objectives
Through the manuscript peer review process for CID, JID, or OFID, you should be able to:
- integrate new discoveries or observations in infectious disease research that can be applied in your work
- use information resources that improve your ability to treat patients or to conduct research in infectious diseases
- identify articles that provide relevant, new data about infectious diseases that could result in additional knowledge
- apply new information that could result in improved healthcare outcomes
Conflicts of Interest
In compliance with ACCME’s Standards for Commercial Support of Continuing Medical Education, anyone in a position to influence content is required to disclose any real or apparent conflicts of interest before participating in a CME-accredited educational activity. IDSA, in collaboration with CID, JID and OFID, identifies and resolves all conflicts of interest prior to manuscript reviews.
|
Name |
Potential Conflicts Declared |
|
Jose Arribas |
Advisory/Consultant Viiv, Janssen, Gilead, MSD
Honoraria Viiv, Janssen, Gilead, MSD
Research Grants/Contracts Merck |
|
Sara Bares |
Expert Testimony Gilead Sciences
Stocks/Bonds Bavarian Nordic
Research Grants/Contracts ViiV Healthcare, Janssen |
|
Taison Bell |
Advisory/Consultant Shionogi, Inc. |
|
Christina Coyle |
Nothing to disclose |
|
Jason Gallagher |
Advisory/Consultant AbbVie, GSK, Imvivyd, Merck, Metheal, Novavax, Qpex, Shionoi, Spero
Research Grants/Contracts Merck |
|
Kim Hanson |
Advisory/Consultant Karius, Delve Bio
Other Renumeration Inflammatix |
|
Emily Heil |
Activities with Other Organizations Society of Infectious Diseases Pharmacists |
|
Vivek Jain |
Nothing to disclose |
|
Colleen Kraft |
Advisory/Consultant Rebiotix/Ferring
Patent/Copyright/License Array primer set for S. aureus resistance mutations, method and system for processing fecal matter for fecal transplant
Research Grants/Contracts Kaiser Permanente, Armata Pharmaceuticals, Ferring Pharmaceuticals |
|
Susanna Naggie |
Advisory/Consultant Pardes Biosciences, Silverback Therapeutics, Vir Biotechnology, BMS/PRA
Stocks/Bonds Vir Biotechnology |
|
Ruvandhi Nathavitharana |
Activities with Other Organizations TB Proof |
|
Jeremy Nel |
Honoraria Abbvie, Novo Nordisk, Viatris
Research Grants/Contracts Novo Nordisc |
|
Luis Ostrosky-Zeichner |
Advisory/Consultant Scynexis, Melinta, GSK, Pulmocide, F2G, Basilea, Pfizer, Gilead, Octapharma, Meiji, Doximity, Eurofins Viracor
Research Grants/Contracts Pfizer, Pulmocide, Scynexis, Basilea, T2 Biosystems, Eurofins Viracor
Activities with Other Organizations Mycoses Study Group and Education Consortium, Immunocompromised Host Society |
|
Jean-Jacques Parienti |
Advisory/Consultant Gilead, Merck, ViiV
Honoraria Gilead, Merck, ViiV
Other Renumeration Gilead, Merck, ViiV
Research Grants/Contracts Gilead, Merck |
|
Robin Patel |
Advisory/Consultant PhAST, Day Zero Diagnostics, DEEPULL DIAGNOSTICS, S.L., Nostics, HealthTrackRx, bioMérieux, CARB-X
Patent/Copyright/License Bordetella pertussis/parapertussis PCR, device/method for sonication, anti-biofilm substance, PET imaging of bacterial infection with a PET probe (pending)
Research Grants/Contracts MicuRx Pharmaceuticals, bioMérieux
Activities with Other Organizations American Society for Microbiology |
|
David Pegues |
Nothing to declare |
|
Federico Perez |
Research Grants/Contracts Pfizer, Merck, Accelerate
Activities with Other Organizations VA Society for Practitioners of Infectious Diseases |
|
Adam Ratner |
Patent/Copyright/License Treatment and Prevention of Gardnerella vaginalis Infections (3 patents)
Activities with Other Organizations American Academy of Pediatrics, Pediatric Infectious Diseases Society |
|
Raymond Razonable |
Honoraria Invivyd
Research Contracts/Grants Gilead, Regeneron
Activities with Other Organizations American Society of Transplantation, Association of Specialty Professors, Alliance of Academic Internal Medicine |
|
Chanu Rhee |
Nothing to declare |
|
Nadine Rouphael |
Advisory/Consultant Moderna, Sanofi, Seqirus, Pfizer
Other Renumeration Moderna, Sanofi
Research Grants/Contracts Merck, Sanofi, Pfizer, Vaccine Company, Immorna |
|
Michael Rybak |
Advisory/Consultant Innovia, AbbVie, T2 Biosystems, Shionogi
Honoraria AbbVie, Shionogi
Research Grants/Contracts Merck, Innoviva, Paratek, AbbVie, T2 Biosystems, Melinta
Activities with Other Organizations Making-A-Difference in Infectious Diseases |
|
Paul Sax |
Advisory/Consultant Gilead, Merck, ViiV, Shinogi
Research Grants/Contracts Gilead, ViiV |
|
Ilan Schwartz |
Activities with Other Organizations Mycoses Study Group Education & Research Consortium |
|
Maunank Shah |
Activities with Other Organizations HIVASSIST Inc |
|
Emmanuel (Chip) Walter |
Advisory/Consultant Iliad Biotechnologies, Vaxcyte, Pfizer
Other Renumeration Vaxcyte, Pfizer
Research Grants/Contracts Pfizer, Moderna, Seqirus, Najit Technologies |
|
Name |
Potential Conflicts Declared |
|
David Andes |
Advisory/Consultant F2G, sFunga, Astellas, Basilea
Research Grants/Contracts Basilea, NA, Kbio
Activities with Other Organizations Clinical and Laboratory Standards Institute, American Society for Microbiology, PLOS Pathogens |
|
Kara Chew |
Advisory/Consultant Pardes Biosciences
Other Renumeration Pfizer, Shionogi |
|
Helen Chu |
Honoraria Merck, Abbvie, Vir, Roche
Activities with Other Organizations Advisory Committee on Immunization Practices |
|
Sara Gianella Weibel |
Nothing to disclose |
|
Audrey Odom John |
Advisory/Consultant Pluton Biosciences
Patent/Copyright/License Patents on antimalarials, antibacterials, and breath biomarkers of malaria; pending patent on breath biomarkers of non-alcoholic fatty liver disease
Activities with Other Organizations Antimicrobial Agents and Chemotherapy |
|
Adam Lauring |
Advisory/Consultant Roche
Research Grants/Contracts Roche |
|
Daniel Leung |
Activities with Other Organizations American Society of Tropical Medicine and Hygiene |
|
Joseph Lewnard |
Advisory/Consultant Pfizer, Merck Sharp & Dohme, VaxCyte, Inc., Valneva SE |
|
Jonathan Li |
Advisory/Consultant Abbvie, Mallinckrodt, Imunon |
|
Anita McElroy |
Nothing to disclose |
|
Ighovwerha Ofotokun |
Advisory/Consultant SCYNEXIS, Inc |
|
Roger Paredes |
Advisory/Consultant Pfizer, Gilead, MSD, GSK, Atea, Lilly, Roche, Astra-Zeneca, ViiV Healthcare, PharmaMar
Honoraria Pfizer, AstraZeneca, Gilead, MSD
Research Grants/Contracts Gilead, MSD, ViiV, PharmaMar |
|
Anne Piantadosi |
Advisory/Consultant Delve Bio
Honoraria Delve Bio
Patent/Copyright/License Patent pending through former employer, Broad Institute |
|
Cindy Sears |
Patent/Copyright/License Patent for bacterial biofilms and cancer; patent pending for discovery of colon receptor for the Bacteroides fragilis toxin
Research Grants/Contracts Janssen, Bristol Myers Squibb |
|
Irini Sereti |
Patent/Copyright/License Methods for the treatment of Kaposi’s sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers
Other Activities Karius, Novartis, Neoimmunotech |
|
Kathryn Stephenson |
Advisory/Consultant Imunon, Bavarian Nordic
Activities with Other Organizations AIDS Research and Human Retroviruses |
|
Jeffrey Tornheim |
Activities with Other Organizations ACTG TB Transformative Science Group |
|
Anne-Catrin Uhlemann |
Research Grants/Contracts Merck
Activities with Other Organizations Infectious Diseases Society of New York |
|
Name |
Potential Conflicts Declared |
|
Sam Aitken |
Advisory/Consultant Shionogi, Merck, Alembic, Entasis, F2G, bioMerieux, GlaxoSmithKline, Melinta
Honoraria Melinta
Activities with Other Organizations Society of Infectious Diseases Pharmacists |
|
Nancie Archin |
Honoraria Gilead
Research Grants/Contracts Gilead |
|
Sandra Arnold |
Research Grants/Contracts Pfizer, Enanta |
|
John Baddley |
Activities with Other Organizations The Transplantation Society, Mycoses Study Group and Research Consortium |
|
Roger Bedimo |
Advisory/Consultant Merck & Co, Inc, ViiV Healthcare, Gilead Sciences, Inc, Shionogi, Janssen Pharmaceuticals
Research Grants/Contracts Merck & Co. |
|
James (Brad) Cutrell |
Advisory/Consultant MDC Associates Inc, Deepull
Activities with Other Organizations Society for Healthcare Epidemiology of America, Texas Infectious Diseases Society, Association of American Medical Colleges |
|
Edward Gardner |
Research Grants/Contracts NIH, Gilead Sciences, ViiV Healthcare, Merck Pharmaceuticals |
|
Martin Hoenigl |
Advisory/Consultant Shionogi, Mundipharma, PharmaH, Gilead, Scynexis, Basilea, F2G, Melinta
Honoraria Mundipharma, Scynexis, Shionogi, Gilead, Astra Zeneca
Other Renumeration Karius, Cape Cod Diagnostics
Research Grants/Contracts FWF, Gilead, Melinta, Mundipharma, Pfizer, Shionogi, Basilea, IMMY, MSD, Pulmocide, Cape Cod Diagnostics
Activities with Other Organizations European Confederation of Medical Mycology, Mycoses Study Group Education and Research Consortium |
|
Hannah Imlay |
Stocks/Bonds Recursion Pharmaceuticals
Family or Other Relations Recursion Pharmaceuticals |
|
Regina LaRocque |
Activities with Other Organizations Greater Boston Physicians for Social Responsibility |
|
Monica Mahoney |
Nothing to disclose |
|
Jen Manne-Goehler |
Advisory/Consultant ViiV |
|
Laura Marks |
Patent/Copyright/License Potentiation of antibiotic treatment with a protein-lipid complex
Research Grants/Contracts Gilead Foundation |
|
Carlos Mejia-Chew |
Nothing to disclose |
|
Jeniel Nett |
Grants/Contracts Failsafe |
|
Obinna Nnedu |
Advisory/Consultant Merck |
|
Dylan Pillai |
Honoraria Becton Dickinson, Biomerieux
Patent/Copyright/License Multiplex LAMP testing with machine learning
Other Renumeration Diasorin |
|
Carlos Seas |
Nothing to disclose |
|
William Short |
Advisory/Consultant ViiV, Gilead
Honoraria ViiV
Research Grants/Contracts Gilead |
|
Andrej Spec |
Advisory/Consultant Scynexis, F2G
Research Grants/Contracts Astellas, Mayne |
|
Francois Venter |
Honoraria Gilead, ViiV, Mylan/Viatris, Merck, Adcock-Ingram, Aspen, Abbott, Roche, J&J, Sanofi, Boehringer Ingelheim, Thermo-Fischer
Other Renumeration ViiV Healthcare, Merck, J&J, Gilead Sciences
Research Grants/Contracts Merck, J&J, Gilead, ViiV, Merck, Novo
Activities with Other Organizations Southern African HIV Clinician Society, Health Justice Initiative, Dira Sengwe |
|
Amy Vittor |
Activities with Other Organizations Florida Clinicians for Climate Action |
|
Laila Woc-Colburn |
Nothing to disclose |
|
Darcy Wooten |
Nothing to disclose |
|
Christina Yek |
Nothing to disclose |